Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
2017 · New England Journal of Medicine · 2,177 citations
https://doi.org/10.1056/nejmoa1702752
R
Richard S. Finkel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
469
Papers
31.5K
Citations
83
h-index
238
i10-index
Richard S. Finkel is an academic researcher from Hospital Sant Joan de Déu Barcelona. The author has contributed to research in topics: Neurogenetic and Muscular Disorders Research & Muscle Physiology and Disorders & RNA modifications and cancer. The author has an h-index of 83, co-authored 399 publications.
ORCID: 0000-0002-9351-7054Papers by this author
worksDiagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
2009 · The Lancet Neurology · 2,004 citations
https://doi.org/10.1016/s1474-4422(09)70271-6
Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
2017 · Neuromuscular Disorders · 991 citations
https://doi.org/10.1016/j.nmd.2017.11.005
Consensus Statement for Standard of Care in Spinal Muscular Atrophy
2007 · Journal of Child Neurology · 917 citations
https://doi.org/10.1177/0883073807305788
Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics
2017 · Neuromuscular Disorders · 642 citations
https://doi.org/10.1016/j.nmd.2017.11.004
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
2019 · Neuromuscular Disorders · 612 citations
https://doi.org/10.1016/j.nmd.2019.09.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat